Study finds mixed results of Adderall as cognitive enhancer (seems to boost emotion more than cognition)

Over the past 15 years there has been grow­ing aware­ness that many col­lege stu­dents with­out an ADHD diag­no­sis use ADHD drugs. On some cam­pus­es, rates of self-report­ed non-med­i­cal use have exceed­ed 30% of stu­dents. The pri­ma­ry rea­son stu­dents report tak­ing ADHD drugs is to enhance their aca­d­e­m­ic per­for­mance. And, the strong major­i­ty of students —…

Read More

Study suggests the real deficit underlying Attention Deficit Disorders is not Attention, but Working Memory

______________________________ Many par­ents have observed that their child with ADHD stays atten­tive and engaged dur­ing ‘high inter­est’ activ­i­ties, e.g., while play­ing video games, but has con­sid­er­able prob­lems stay­ing focused on less inher­ent­ly engag­ing tasks, e.g., doing school­work. This dis­crep­an­cy in atten­tion dur­ing pre­ferred and non-pre­­ferred activ­i­ties has led some to

Read More

Trend: Biopharma embraces digital cognitive assessments to identify behavioral health biomarkers

_______ The hunt for behav­ioral health bio­mark­ers is har­ness­ing dig­i­tal health at the research stage (Med­C­i­ty News): “Dig­i­tal health com­pa­nies are going through an inter­est­ing trans­for­ma­tion as research insti­tu­tions real­ize the ben­e­fit of their tech­nol­o­gy to col­lect and man­age data for a host of stud­ies. The bio­phar­ma industry’s embrace of some dig­i­tal health tools to manage…

Read More

Digital brain health goes global: Savonix raises $5.1 million to commercialize mobile neurocognitive assessment in the US, China and Japan

— Savonix gets $5.1M to advance dig­i­tal neu­rocog­ni­tive assess­ment (Mobi­Health News): “San Fran­­cis­­co-based Savonix, mak­er of an app for neu­rocog­ni­tive assess­ment, has raised $5.1 mil­lion in a new round of fund­ing. Dig­iTx Part­ners led the round with addi­tion­al con­tri­bu­tion from ReThink Impact.

Read More